Edwards Lifesciences Corporatio - stock earnings
EW Upcoming estimated earnings
| Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
|---|---|---|---|---|
| July 24, 2024 BeforeMarket | - / - | 1.6 billion | - / 1.7 billion | 1.7 billion |
EW Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2024Q1 | 351.9 million USD | 1.6 billion USD |
| 2023Q4 | 369.9 million USD | 1.5 billion USD |
| 2023Q3 | 384.9 million USD | 1.5 billion USD |
| 2023Q2 | 307.1 million USD | 1.5 billion USD |
| 2023Q1 | 340.5 million USD | 1.5 billion USD |
| 2022Q4 | 398.4 million USD | 1.3 billion USD |
| 2022Q3 | 343.5 million USD | 1.3 billion USD |
| 2022Q2 | 406.4 million USD | 1.4 billion USD |
| 2022Q1 | 373.6 million USD | 1.3 billion USD |
| 2021Q4 | 335.3 million USD | 1.3 billion USD |
| 2021Q3 | 340.1 million USD | 1.3 billion USD |
| 2021Q2 | 489.5 million USD | 1.4 billion USD |
| 2021Q1 | 338.2 million USD | 1.2 billion USD |
| 2020Q4 | 309.5 million USD | 1.2 billion USD |
| 2020Q3 | 325.2 million USD | 1.1 billion USD |
| 2020Q2 | -121.9 million USD | 925.0 million USD |
| 2020Q1 | 310.6 million USD | 1.1 billion USD |
| 2019Q4 | 280.2 million USD | 1.2 billion USD |
| 2019Q3 | 274.7 million USD | 1.1 billion USD |
| 2019Q2 | 242.3 million USD | 1.1 billion USD |
| 2019Q1 | 249.7 million USD | 993.0 million USD |
| 2018Q4 | 7.0 million USD | 977.7 million USD |
| 2018Q3 | 225.9 million USD | 906.6 million USD |
| 2018Q2 | 282.7 million USD | 943.7 million USD |
| 2018Q1 | 206.6 million USD | 894.8 million USD |
| 2017Q4 | 35.7 million USD | 888.5 million USD |
| 2017Q3 | 170.1 million USD | 821.5 million USD |
| 2017Q2 | 186.1 million USD | 841.8 million USD |
| 2017Q1 | 230.2 million USD | 883.5 million USD |
| 2016Q4 | 158.5 million USD | 767.7 million USD |
| 2016Q3 | 141.4 million USD | 739.4 million USD |
| 2016Q2 | 126.6 million USD | 759.3 million USD |
| 2016Q1 | 143.0 million USD | 697.3 million USD |
| 2015Q4 | 140.7 million USD | 671.1 million USD |
| 2015Q3 | 118.1 million USD | 615.5 million USD |
| 2015Q2 | 112.7 million USD | 616.8 million USD |
| 2015Q1 | 123.4 million USD | 590.3 million USD |
| 2014Q4 | 109.2 million USD | 618.0 million USD |
| 2014Q3 | 94.6 million USD | 607.4 million USD |
| 2014Q2 | 547.0 million USD | 575.1 million USD |
| 2014Q1 | 60.3 million USD | 522.4 million USD |
| 2013Q4 | 75.8 million USD | 536.0 million USD |
| 2013Q3 | 76.8 million USD | 495.6 million USD |
| 2013Q2 | 93.3 million USD | 517.2 million USD |
| 2013Q1 | 143.9 million USD | 496.7 million USD |
| 2012Q4 | 91.1 million USD | 510.5 million USD |
| 2012Q3 | 69.2 million USD | 447.9 million USD |
| 2012Q2 | 67.8 million USD | 482.0 million USD |
| 2012Q1 | 65.1 million USD | 459.2 million USD |
| 2011Q4 | 63.1 million USD | 430.2 million USD |
| 2011Q3 | 51.6 million USD | 412.7 million USD |
| 2011Q2 | 58.1 million USD | 431.2 million USD |
| 2011Q1 | 63.9 million USD | 404.5 million USD |
| 2010Q4 | 64.8 million USD | 392.4 million USD |
| 2010Q3 | 48.0 million USD | 348.9 million USD |
| 2010Q2 | 57.5 million USD | 365.2 million USD |
| 2010Q1 | 47.7 million USD | 340.5 million USD |
| 2009Q4 | 47.6 million USD | 346.7 million USD |
| 2009Q3 | 73.5 million USD | 325.7 million USD |
| 2009Q2 | 47.5 million USD | 335.5 million USD |
| 2009Q1 | 60.5 million USD | 313.5 million USD |
| 2008Q4 | 38.1 million USD | 309.7 million USD |
| 2008Q3 | 32.9 million USD | 303.6 million USD |
| 2008Q2 | 39.7 million USD | 327.6 million USD |
| 2008Q1 | 18.2 million USD | 296.8 million USD |
| 2007Q4 | 15.8 million USD | 293.0 million USD |
| 2007Q3 | 29.1 million USD | 261.4 million USD |
| 2007Q2 | 34.9 million USD | 272.6 million USD |
| 2007Q1 | 33.2 million USD | 264.1 million USD |
| 2006Q4 | 20.7 million USD | 265.6 million USD |
| 2006Q3 | 27.8 million USD | 247.4 million USD |
| 2006Q2 | 36.1 million USD | 267.3 million USD |
| 2006Q1 | 46.0 million USD | 257.0 million USD |
| 2005Q4 | 38.6 million USD | 249.7 million USD |
| 2005Q3 | -4.4 million USD | 240.9 million USD |
| 2005Q2 | 13.9 million USD | 258.2 million USD |
| 2005Q1 | 31.2 million USD | 249.1 million USD |
| 2004Q4 | 25.9 million USD | 237.1 million USD |
| 2004Q3 | 12.4 million USD | 224.8 million USD |
| 2004Q2 | 25.5 million USD | 234.6 million USD |
| 2004Q1 | -62.1 million USD | 235.0 million USD |
| 2003Q4 | 18.9 million USD | 224.1 million USD |
| 2003Q3 | 24.5 million USD | 206.1 million USD |
| 2003Q2 | 21.1 million USD | 217.8 million USD |
| 2003Q1 | 14.5 million USD | 212.5 million USD |
| 2002Q4 | 21.7 million USD | 203.1 million USD |
| 2002Q3 | -17.4 million USD | 165.8 million USD |
| 2002Q2 | 30.6 million USD | 172.8 million USD |
| 2002Q1 | 20.8 million USD | 162.3 million USD |
| 2001Q4 | 16.5 million USD | 159.9 million USD |
| 2001Q3 | 14.5 million USD | 147.8 million USD |
| 2001Q2 | -55.7 million USD | 192.4 million USD |
| 2001Q1 | 12.7 million USD | 191.9 million USD |
| 2000Q4 | 24.8 million USD | 216.5 million USD |
| 2000Q3 | 4.4 million USD | 185.8 million USD |
| 2000Q2 | -309.0 million USD | 205.0 million USD |
| 2000Q1 | 17.0 million USD | 226.0 million USD |
| 1999Q4 | 20.0 million USD | 234.0 million USD |
EW Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 1.4 billion USD | 6.0 billion USD |
| 2022 | 1.5 billion USD | 5.4 billion USD |
| 2021 | 1.5 billion USD | 5.2 billion USD |
| 2020 | 823.4 million USD | 4.4 billion USD |
| 2019 | 1.0 billion USD | 4.3 billion USD |
| 2018 | 722.2 million USD | 3.7 billion USD |
| 2017 | 622.1 million USD | 3.4 billion USD |
| 2016 | 569.5 million USD | 3.0 billion USD |
| 2015 | 494.9 million USD | 2.5 billion USD |
| 2014 | 811.1 million USD | 2.3 billion USD |
| 2013 | 391.7 million USD | 2.0 billion USD |
| 2012 | 293.2 million USD | 1.9 billion USD |
| 2011 | 236.7 million USD | 1.7 billion USD |
| 2010 | 218.0 million USD | 1.4 billion USD |
| 2009 | 229.1 million USD | 1.3 billion USD |
| 2008 | 128.9 million USD | 1.2 billion USD |
| 2007 | 113.0 million USD | 1.1 billion USD |
| 2006 | 130.5 million USD | 1.0 billion USD |
| 2005 | 79.3 million USD | 997.9 million USD |
| 2004 | 1.7 million USD | 931.5 million USD |
| 2003 | 79.0 million USD | 860.5 million USD |
| 2002 | 55.7 million USD | 704.0 million USD |
| 2001 | -12.0 million USD | 692.0 million USD |
| 2000 | -272.0 million USD | 804.0 million USD |
| 1999 | 82.0 million USD | 905.0 million USD |
EW
Price: $87.03
52 week price:
Earnings Per Share: 2.32 USD
P/E Ratio: 37.38
Exchange: NYQ
Sector: Healthcare
Industry: Medical Devices
Volume: 2.2 million
Ebitda: 328.1 millionMarket Capitalization: 52.3 billion